7556 - GILEAD SCIENCES INC - 2-25-1997 - 000-19731 - EXHIBIT 10.42 - 183188-141131-259177.pdf

Exhibit 10.42 CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, IS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. DEVELOPMENT AND LICENSE AGREEMENT BY AND BETWEEN GILEAD SCIENCES, INC. AND F. HOFFMANN-LA ROCHE LTD AND HOFFMANN-LA ROCHE INC. SEPTEMBER 27, 1996 TABLE OF CONTENTS ARTICLE 1. DEFINITIONS . . . . . . . . . . . . . . . . . . . . . . . . 1 1.1 "Affiliate" . . . . . . . . . . . . . . . . . . . . . . . . 1.2 "Budget". . . . . . . . . . . . . . . . . . . . . . . . . . 1.3 "Cost of Goods Sold". . . . . . . . . . . . . . . . . . . . 1.4 "Cover" . . . . . . . . . . . . . . . . . . . . . . . . . . 1.5 "Development Costs" . . . . . . . . . . . . . . . . . . . . 1.6 "Development Plan". . . . . . . . . . . . . . . . . . . . . 1.7 "European Union". . . . . . . . . . . . . . . . . . . . . . 1.8 "First Commercial Sale" . . . . . . . . . . . . . . . . . . 1.9 "Generically Equivalent Product". . . . . . . . . . . . . . 1.10 "Gilead Know-How" . . . . . . . . . . . . . . . . . . . . . 1.11 "Gilead Patent Rights". . . . . . . . . . . . . . . . . . . 1.12 "IND" (or "Investigational New Drug Application") . . . . . 1.13 "Joint Patent Rights" . . . . . . . . . . . . . . . . . . . 1.14 "NDA" (or "New Drug Application") . . . . . . . . . . . . . 1.15 "Net Sales" . . . . . . . . . . . . . . . . . . . . . . . . 1.16 "Phase III Clinical Trial". . . . . . . . . . . . . . . . . 1.17 "Product(s)". . . . . . . . . . . . . . . . . . . . . . . . 1.18 "Proprietary Information" . . . . . . . . . . . . . . . . . 1.19 "Roche Know-How". . . . . . . . . . . . . . . . . . . . . . 1.20 "Roche Patent Rights" . . . . . . . . . . . . . . . . . . . 1 2 2 2 2 3 3 3 3 3 3 3 4 4 4 4 5 5 5 5